Open by design

How we do our research.

Not a portal that asks you to donate data. A window into how Goglo clinicians work, what we measure, and what we are willing to publish.

Where we are today

Goglo is building a structured hair-loss registry inside everyday clinical care. We have not yet published peer-reviewed papers from it, and we will not claim outcomes we cannot show. This page exists so you can watch that work take shape rather than take our word for it.

Method

Four rules we hold to

Measured, not guessed

Every scalp scan records density, terminal-to-vellus ratio and miniaturisation with the same six-zone protocol, so one patient's month-6 can be compared with their own month-0 — not with a marketing photo.

A doctor signs every AI reading

AI output is always labelled an estimate until a clinician reviews it. Nothing reaches a patient chart as fact without a named doctor's confirmation.

Prescription with reasoning

When a medicine is prescribed, the reasoning card records why it was chosen for this phenotype, what is expected by when, and what would make us change course.

Follow-up is part of the treatment

Monthly check-ins capture shedding, adherence and side effects. Care that is not followed up cannot be studied — and cannot be improved.

Collaboration

Hair loss is rarely only about hair

Cohort clubs group patients whose hair loss shares a driver. Each club has more than one specialty reviewing it, so the plan is built by the doctors who actually own that cause.

Thyroid & hair loss

Dermatology + Endocrinology

Thyroid panels reviewed alongside scalp findings before any regrowth plan is finalised.

PCOS & post-partum

Dermatology + Gynaecology

Hormonal timelines, pregnancy and lactation safety checks built into the prescribing flow.

Post-oncology regrowth

Dermatology + Oncology follow-up

Regrowth expectations set against treatment history rather than generic timelines.

Scalp health & inflammation

Trichology + Dermatopathology

Seborrhoeic, lichen planopilaris and scarring patterns separated early, before graft planning.

Reviewed across borders

Difficult cases are presented to clinicians in more than one country before a surgical plan is signed. The intent is simple: a second and third opinion should be routine, not something a patient has to chase.

  • · Multi-centre case panels using the same scan protocol
  • · Shared grading so results mean the same thing in every centre
  • · Public invitations to clinicians, academics and public-health bodies working in hair medicine

Ethics

What we promise patients

Consent is separate from care

Using Goglo for treatment never enrols you in research. Research consent is a distinct, revocable opt-in, and withdrawing it changes nothing about your care.

Ethics review before any study

Anything we call a study goes through an institutional ethics committee first. Until that approval exists, we describe our work as internal quality tracking — not research.

De-identified at the source

Cohort views are built on de-identified records. Photographs never leave the clinical chart for research use without an explicit, separate permission.

Local language, local context

Check-ins and consent text are being translated so patients answer in the language they think in. A questionnaire nobody understands produces data nobody should trust.

Roadmap

What comes next, in order

  1. Now

    Structured registry

    Standardised scans, histories and monthly reviews collected inside routine care across partner centres.

  2. Next

    Ethics submissions

    Protocol and consent documents prepared for institutional ethics committee review before any analysis is published.

  3. Then

    Cohort reports

    Club-level outcome summaries shared publicly on this page — including the results that did not work.

  4. Ongoing

    Clinician panels

    Quarterly multi-country case panels where surgeons and physicians review difficult cases together.

Publications

Nothing published yet. When a manuscript is submitted, accepted or rejected, it will be listed here with its status — including studies whose findings were negative.

Clinician, researcher or health body?

We welcome collaborators who want to review protocols, join case panels or help translate patient materials into more Indian and regional languages.

Find a partner centre